Basem William is an Oncology physician affiliated with OhioHealth. OpenAlex indexes 239 publications with 4,503 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1050 Delaware Ave
Marion, OH 433026416
Telephone
740-383-7830Provider last certified this registry record 26 May 2021.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- KYOWA KIRIN, INC.Program year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- Adaptive Biotechnologies CorporationProgram year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
31.4%Kinase inhibitor16.3%Brukinsa70%Imbruvica30%Part D<11 patientsRetinoid5.7%Bexarotene100%Part D<11 patients+ 2 more classes in this area
Dermatology
15.9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor15.9%Acyclovir100%Part D≥16 patientsNervous system
14%Phenothiazine5.7%Prochlorperazine Maleate100%Part D<11 patientsGabapentinoids4.2%Gabapentin100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma
Journal for ImmunoTherapy of Cancer
2021 - NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Journal of the National Comprehensive Cancer Network
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Yakubov, MD
OhioHealth
Nirav Vora, MD
OhioHealth
Yvonne Efebera, MD
OhioHealth
Subha Raman, MD
OhioHealth
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”